Regulation of c-Fes tyrosine kinase and biological activities by N- terminal coiled-coil oligomerization domains

Molecular and Cellular Biology

Volumn 19, Issue 12, 1999, Pages 8335-8343

  Cheng, Haiyun ^a   Rogers, Jim A ^a   Dunham, Nancy A ^a   Smithgall, Thomas E ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; PROTEIN TYROSINE KINASE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; GENE DELETION; GENE DISRUPTION; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT;

ANIMALIA; MAMMALIA;

EID: 0033506708     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.12.8335     Document Type: Article

References (46)

1. Alexandropoulos, K., and D. Baltimore. 1997. Coordinate activation of c-Src by SH3 and SH2 binding sites on a novel, p130Cas-related protein, Sin. Genes Dev. 10:1341-1355.
2. Briggs, S. D., M. Sharkey, M. Stevenson, and T. E. Smithgall. 1997. SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1. J. Biol. Chem. 272:17899-17902.
3. Briggs, S. D., and T. E. Smithgall. 1999. SH2-kinase linker mutations release Hck tyrosine kinase and transforming activities in rat-2 fibroblasts. J. Biol. Chem. 274:26579-26583.
4. Brown, M. T., and J. A. Cooper. 1996. Regulation, substrates, and functions of Src. Biochim. Biophys. Acta 1287:121-149.
5. Erpel, T., G. Superti-Furga, and S. A. Courtneidge. 1995. Mutational analysis of the Src SH3 domain: the same residues of the ligand binding surface are important for intra-and intermolecular interactions. EMBO J. 14:963-975.
6. c-fes on its catalytic activity and ability to promote myeloid differentiation in K-562 cells. Biochemistry 32:6995-7001.
7. Feldman, R. A., J. L. Gabrilove, J. P. Tam, M. A. S. Moore, and H. Hanafusa. 1985. Specific expression of the human cellular fps/fes-encoded protein NCP92 in normal and leukemic myeloid cells. Proc. Natl. Acad. Sci. USA 82:2379-2383.
8. Feldman, R. A., D. R Lowy, W. C. Vass, and T. J. Velu. 1989. A highly efficient retroviral vector allows detection of the transforming activity of the human c-fps/fes proto-oncogene. J. Virol. 63:5469-5474.
9. Golub, T. R., A. Goga, G. F. Barker, D. E. H. Alar, J. McLaughlin, S. K. Boblander, J. D. Rowley, O. N. Witte, and D. G. Gilliland. 1996. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol. Cell. Biol. 16:4107-4116.
10. Gonfloni, S., J. C. Williams, K. Hattula, A. Weijland, R. K. Wierenga, and G. Superti-Furga. 1997. The role of the linker between the SH2 domain and catalytic domain in the regulation and function of Src. EMBO J. 16:7261-7271.
11. Greer, P., J. Haigh, G. Mbamalu, W. Khoo, A. Bernstein, and T. Pawson. 1994. The Fps/Fes protein-tyrosine kinase promotes angiogenesis in transgenic mice. Mol. Cell. Biol. 14:6755-6763.
12. Greer, P. A., K. Meckling-Hansen, and T. Pawson. 1988. The human c-fps/fes gene product expressed ectopically in rat fibroblasts is nontransforming and has restrained protein-tyrosine kinase activity. Mol. Cell. Biol. 8:578-587.
13. Grotten, J., N. Heisterkamp, M. Shibuya, H. Hanafusa, and J. R. Stephenson. 1983. Transforming genes of avian (v-fps) and mammalian (v-fes) retroviruses correspond to a common cellular locus. Virology 125:480-486.
14. Guo, X. Y., J. M. Cuillerot, T. Wang, Y. Wu, R. Arlinghaus, D. Claxton, C. Bachier, J. Greenberger, I. Colombowala, and A. B. Deisseroth. 1998. Peptide containing the BCR oligomerization domain (AA 1-160) reverses the transformed phenotype of p210bcr-abl positive 32D myeloid leukemia cells. Oncogene 17:825-833.
15. Hampe, A., I. Laprevotte, F. Galibert, L. A. Fedele, and C. J. Sherr. 1982. Nucleotide sequences of feline retroviral oncogenes (v-fes) provide evidence for a family of tyrosine-specific protein kinase genes. Cell 30:775-785.
16. Hanafusa, T., L.-H. Wang, S. M. Anderson, R. E. Karess, W. S. Hayward, and H. Hanafusa. 1980. Characterization of the transforming gene of Fujinami sarcoma virus. Proc. Natl. Acad. Sci. USA 77:3009-3013.
17. Hanazono, Y., S. Chiba, K. Sasaki, H. Mano, A. Miyajima, K. Arai, Y. Yazaki, and H. Hirai. 1993. c-fps/fes protein-tyrosine kinase is implicated in a signaling pathway triggered by granulocyte-macrophage colony-stimulating factor and interleukin-3. EMBO J. 12:1641-1646.
18. Hanazono, Y., S. Chiba, K. Sasaki, H. Mano, Y. Yazaki, and H. Hirai. 1993. Erythropoietin induces tyrosine phosphorylation and kinase activity of the c-fps/fes proto-oncogene product in human erythropoietin-responsive cells. Blood 81:3193-3196.
19. Huang, C-C., C. Hammond, and J. M. Bishop. 1984. Nucleotide sequence of v-fps in the PRC II strain of avian sarcoma virus. J. Virol. 50:125-131.
20. Izuhara, K., R. A. Feldman, P. Greer, and N. Harada. 1994. Interaction of the c-fes proto-oncogene product with the interleukin-4 receptor. J. Biol. Chem. 269:18623-18629.
21. Kamps, M. P., J. E. Buss, and B. M. Sefton. 1986. Rous sarcoma virus transforming protein lacking myristic acid phosphorylates known polypeptide substrates without inducing transformation. Cell 45:105-112.
22. Lee, W.-H., K. Bister, A. Pawson, T. Robins, C. Moscovici, and P. H. Duesberg. 1980. Fujinami sarcoma virus: an avian RNA tumor virus with a unique transforming gene. Proc. Natl. Acad. Sci. USA 77:2018-2022.
23. Li, J., and T. E. Smithgall. 1996. Co-expression with Bcr induces activation of the Fes tyrosine kinase and phosphorylation of specific N-terminal Bcr tyrosine residues. J. Biol. Chem. 271:32930-32936.
24. Li, J., and T. E. Smithgall. 1998. Fibroblast transformation by Fps/Fes tyrosine kinases requires Ras, Rac and Cdc42 and induces extracellular signal-regulated and c-Jun N-terminal kinase activation. J. Biol. Chem. 273: 13828-13834.
25. Lozzio, B. B., C. B. Lozzio, E. G. Bamberger, and A. S. Feliu. 1981. A multipotential leukemia cell line (K-562) of human origin. Proc. Soc. Exp. Biol. Med. 166:546-550.
26. Lupas, A. 1996. Prediction and analysis of coiled-coil structures. Methods Enzymol. 266:513-525.
27. Lupas, A., M. Van Dyke, and J. Stock. 1991. Predicting coiled coils from protein sequences. Science 252:1162-1164.
28. MacDonald, I., J. Levy, and T. Pawson. 1985. Expression of the mammalian c-fes protein in hematopoietic cells and identification of a distinct fes-related protein. Mol. Cell. Biol. 5:2543-2551.
29. Maru, Y., K. L. Peters, D. E. H. Afar, M. Shibuya, O. N. Witte, and T. E. Smithgall. 1995. Tyrosine phosphorylation of BCR by FPS/FES protein-tyrosine kinases induces association of BCR with GRB-2/SOS. Mol. Cell. Biol. 15:835-842.
30. Matsuda, T., T. Fukada, M. Takahashi-Tezuka, Y. Okuyama, Y. Fujitani, Y. Hanazono, H. Hirai, and T. Hirano. 1995. Activation of Fes tyrosine kinase by gp130, an interleukin-6 family cytokine signal transducer, and their association. J. Biol. Chem. 270:11037-1109.
31. McWhirter, J. R., D. L. Galasso, and J. Y. J. Wang. 1993. A coiled-coil oligomerization domain of bcr is essential for the transforming function of bcr-abl oncoproteins. Mol. Cell. Biol. 13:7587-7595.
32. Moarefi, I., M. LaFevre-Bernt, F. Sichert, M. Huse, C.-H. Lee, J. Kuriyan, and W. T. Miller. 1997. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature 385:650-653.
33. Muller, A. J., J. C. Young, A. M. Pendergast, M. Pondel, R. N. Landau, D. R. Littman, and O. N. Witte. 1991. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol. Cell. Biol. 11:1785-1792.
34. gag-fps. Biochem. Biophys. Res. Commun. 211:447-453.
35. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-liter helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
36. Read, R. D., J. M. Lionberger, and T. E. Smithgall. 1997. Oligomerization of the Fes tyrosine kinase: evidence for a coiled-coil domain in the unique N-terminal region. J. Biol. Chem. 272:18498-18503.
37. Rogers, J. A., R. D. Read, J. Li, K. L. Peters, and T. E. Smithgall. 1996. Autophosphorylation of the Fes tyrosine kinase: evidence for an intermolecular mechanism involving two kinase domain tyrosine residues. J. Biol. Chem. 271:17519-17525.
38. Shibuya, M., and H. Hanafusa. 1982. Nucleotide sequence of Fujinami sarcoma virus: evolutionary relationship of its transforming gene with transforming genes of other sarcoma viruses. Cell 30:787-795.
39. Sicheri, F., I. Moarefi, and J. Kuriyan. 1997. Crystal structure of the Src family tyrosine kinase Hck. Nature 385:602-609.
40. Smithgall, T. E., G. Yu, and R. I. Glazer. 1988. Identification of the differentiation-associated p93 tyrosine protein kinase of HL-60 leukemia cells as the product of the human c-fes locus and its expression in myelomonocytic cells. J. Biol. Chem. 263:15050-15055.
41. Van Etten, R. A. 1999. Cycling, stressed-out and nervous: cellular functions of c-Abl. Trends Cell Biol. 9:179-186.
42. Weinmaster, G., M. J. Zoller, and T. Pawson. 1986. A lysine in the ATP-binding site of P130gag-fps is essential for protein-tyrosine kinase activity. EMBO J. 5:69-76.
43. gag-fps modulates its biological activity. Cell 37:559-568.
44. Williams, J. C., A. Weijland, S. Gonfloni, A. Thompson, S. A. Courtneidge, G. Superti-Furga, and R. K. Wierenga. 1997. The 2.35 Å crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions. J. Mol. Biol. 274:757-775.
45. Xu, W., S. C. Harrison, and M. J. Eck. 1997. Three-dimensional structure of the tyrosine kinase c-Src. Nature 385:595-602.
46. Yu, G., T. E. Smithgall, and R. I. Glazer. 1989. K562 leukemia cells transfected with the human c-fes gene acquire the ability to undergo myeloid differentiation. J. Biol. Chem. 254:10276-10281.